|
• Related Discussion Forum
Messages
As a ValueForum member, this section would contain TXMD message board posts where the
ticker symbol TXMD has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership
-- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.
|
Related news from  |
Fri, 29 Mar 2024
20:00:00 +0000 |
TherapeuticsMD Announces Full Year 2023 Financial Results
BOCA RATON, Fla., March 29, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023.
|
Tue, 12 Mar 2024
15:40:02 +0000 |
25 Countries With Highest Abortion Rates
In this article, we will be taking a look at the 25 countries with highest abortion rates. If you do not want to learn about the global pregnancy care products market, head straight to the 5 Countries With Highest Abortion Rates. The prevalence of abortion rates varies significantly across nations, shedding light on complex socio-political, […]
|
Wed, 31 Jan 2024
04:20:31 +0000 |
12 Best Prenatal Vitamins For Pregnant Women
In this article, we will be taking a look at the 12 best prenatal vitamins for pregnant women. If you are not interested in reading about the market insights, head straight to the 5 Best Prenatal Vitamins For Pregnant Women. Discovering the best prenatal vitamins is crucial for the well-being of expectant mothers and their growing babies. […]
|
Tue, 14 Nov 2023
21:05:00 +0000 |
TherapeuticsMD Announces Third Quarter 2023 Financial Results
BOCA RATON, Fla., November 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2023.
|
Mon, 14 Aug 2023
10:50:00 +0000 |
TherapeuticsMD Announces Second Quarter 2023 Financial Results
BOCA RATON, Fla., August 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the second quarter ended June 30, 2023.
|
Mon, 15 May 2023
20:05:00 +0000 |
TherapeuticsMD Announces First Quarter 2023 Financial Results
BOCA RATON, Fla., May 15, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2023.
|
|
VF Mobile